Sai Life Sciences Ltd share price logo

Sai Life Sciences Share Price

NSE: SAILIFE

BSE: 544306

Small Cap

Healthcare Sector

₹953.05

-55.80

(-5.53%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sai Life Sciences Stock Performance

as on March 13, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹938.00
    ₹1,005.40
    downward going graph

    1.58%

    Downside

    5.49%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹636.10
    ₹1,084.00
    downward going graph

    33.26%

    Downside

    13.74%

    Upside

    downward going graph

Sai Life Sciences share price movements today

Previous Close
₹1,008.85
Open
₹998.00
Volume
6.47L
Upper Circuit
₹1,210.60
Lower Circuit
₹807.10
Day's Low - High
₹938.00 - ₹1,005.40
52 Week Low - High
₹636.10 - ₹1,084.00

Sai Life Sciences Historical Returns

1 Month Return
+ 3.52 %
3 Month Return
+ 4.82 %
1 Year Return
+ 35.21 %
3 Year Return
+ 24.64 %
5 Year Return
+ 24.64 %

Sai Life Sciences Fundamentals

as on March 13, 2026 at 4:01 pm IST

Market Cap

₹20,182.56 Cr

Return on Equity (ROE)

10.92

PE Ratio (TTM)

59.86

Return on capital employed (ROCE)

13.87

Industry PE ratio

42.4

Beta (LTM)

1.34

P/B Ratio

7.33

Dividend Yield

0

PEG Ratio

-3.08

Quarterly Earnings Growth YOY

86.41

EPS (TTM)

8.16

Sector

Pharmaceuticals

Book Value

102.12

Sai Life Sciences Stock Valuation

as on March 13, 2026 at 4:01 pm IST

Sai Life Sciences in the last 5 years

  • Overview

  • Trends

Lowest (18.46x)

January 27, 2025

Industry (42.40x)

March 13, 2026

Today (59.86x)

March 13, 2026

Highest (89.55x)

April 15, 2025

LowHigh

Today’s Price to Earnings Ratio: 59.86x

Sai Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sai Life Sciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sai Life Sciences Ltd image
Sai Life Sciences Ltd
BUY20,182.564.93%0.581701,694
Windlas Biotech Ltd image
Windlas Biotech Ltd
NA1,524.6215.53%0.5360759
Accretion Pharmaceuticals Ltd image
Accretion Pharmaceuticals Ltd
NA71.48-4.5%0.00657
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA10.71-6%0.00-328
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,737.943588.18%0.00932
See all

Market expectation of Sai Life Sciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Sai Life Sciences Stock’s Investor Sentiment and Interest

Investment in Sai Life Sciences Ltd Shares on INDmoney has dropped by -20.51% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-20.51% versus previous 30 day period

Search interest for Sai Life Sciences Ltd Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Sai Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
383.63
439.21
279.72
395.56
439.78
579.51
496.42
537.47
556.46
Other Income
11.29
3.34
8.11
9.95
9.12
9.6
9.9
15.33
8.38
Total Income
394.92
442.55
287.84
405.52
448.89
589.11
506.32
552.8
564.84
Expenses
287.29
314.55
253.61
293.34
320.03
421.93
375.49
391.65
376.9
Operating Profit
96.34
124.66
26.11
102.22
119.75
157.58
120.93
145.82
179.56
Operating Profit Margin %
25.11%
28.38%
9.33%
25.84%
27.23%
27.19%
24.36%
27.13%
32.27%
Profit Before Interest, Tax and Depreciation
107.63
128
34.23
112.17
128.87
167.17
130.84
161.15
187.94
Interest
23.28
20.89
21.22
20.93
23.13
10.89
12.36
9.35
9.7
Depreciation
31.41
31.05
31.07
35.92
34.09
37.49
37.72
39.75
44.08
Profit Before Tax
52.94
76.06
-18.06
55.32
71.65
118.79
80.76
112.05
134.16
Tax Paid
13.33
19.92
-4.57
13.82
17.8
30.53
20.3
28.2
33.8
Profit After Tax
39.61
56.13
-13.5
41.51
53.85
88.27
60.46
83.84
100.38
Total Net profit including share of profit / Loss from associate company
39.61
56.13
-13.5
41.51
53.85
88.27
60.46
83.84
100.38
EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
Actual EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
Adjusted EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
Diluted EPS
2.17
30.7
-0.74
2.21
2.84
4.14
2.9
3.93
4.71

Sai Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
869.59
1,217.14
1,465.18
1,694.57
Other Income
28.15
27.97
29.09
36.78
Total Income
897.74
1,245.11
1,494.27
1,731.35
Expenses
748.31
1,052.21
1,179.69
1,288.91
Operating Profit
121.28
164.93
285.49
405.66
Operating Profit Margin %
13.95%
13.55%
19.48%
23.94%
Profit Before Interest, Tax and Depreciation
149.43
192.9
314.58
442.44
Interest
49.57
77.06
85.91
76.16
Depreciation
90.16
99.43
119.44
138.57
Profit Before Tax
9.7
16.41
109.23
227.71
Tax Paid
3.47
6.42
26.43
57.57
Profit After Tax
6.23
9.99
82.81
170.13
Total Net profit including share of profit / Loss from associate company
6.23
9.99
82.81
170.13
EPS
3.47
7.51
46.44
8.83
Actual EPS
3.47
7.51
46.44
8.83
Adjusted EPS
3.47
7.51
46.44
8.83
Diluted EPS
3.47
7.51
46.44
8.61

Sai Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
129.14
115.5
-36.38
104.87
219.4
263.09
314.05
Cash Flow from Investing Activities
-157.67
-261.69
-259.89
-101.64
-99
-191.35
-536.39
Cash Flow from Financing Activities
267.54
-4.07
295.51
71.92
-200.65
-95.31
301.43
Net Cash Flow
239
-150.26
-0.78
75.15
-80.25
-23.56
79.08

Sai Life Sciences Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
39.64%
35.24%
35.24%
35.17%
35.15%
34.94%
34.7%
DII
0%
5.61%
11.95%
13.26%
21.64%
29.91%
31.41%
FII
0%
7.64%
11.72%
12.36%
14.58%
22.5%
21.4%
Public
0%
51.52%
41.09%
39.21%
28.64%
12.65%
12.49%
Total Outstanding Shares
18,39,20,340
20,79,89,529
20,79,89,529
20,84,14,389
20,85,45,302
20,97,49,267
21,12,31,216
Total Shareholders
70
5,72,970
1,81,122
1,40,677
1,26,380
1,19,705
1,14,820

Mutual Funds that own Sai Life Sciences Stock

Check out the Mutual Funds with significant holdings in Sai Life Sciences.

Sai Life Sciences Corporate Actions

View detailed summary of the earnings and dividend history of Sai Life Sciences.

  • Sai Life Sciences Ltd Earnings Results

    Sai Life Sciences Ltd’s net profit jumped 86.41% since last year same period to ₹100.38Cr in the Q3 2025-2026. On a quarterly growth basis, Sai Life Sciences Ltd has generated 19.73% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sai Life Sciences Stock

Check stock indices that include Sai Life Sciences.

Nifty 500

₹21,391.20

-2.31 (▲506.30%)

S&P BSE 250 SmallCap

₹5,875.64

-2.67 (▲160.95%)

Nifty Smallcap 250

₹14,857.50

-2.68 (▲408.95%)

BSE Healthcare

₹42,787.59

-2.06 (▲899.47%)

Nifty MidSmallcap 400

₹18,239.35

-2.68 (▲502.65%)

BSE 500

₹33,516.43

-2.29 (▲784.06%)

S&P BSE 400 MidSmallCap

₹10,882.59

-2.63 (▲293.93%)

Insights on Sai Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 26.17% to 27.57% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SAILIFE stock has moved down by -6.3%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 34.94% to 34.70% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 22.50% to 21.40% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 12.65% to 12.49% in Dec 2025 quarter

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company dated January 25 1999 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies Andhra Pradesh on February 17 1999. Subsequently the Company name was changed from Sai Dru Syn Laboratories Limited to Sai Life Sciences Limited dated December 16 2003.Thereafter the name of the Company was changed from Sai Life Sciences Limited to Sai Advantium Pharma Limited dated August 30 2006 issued by the Registrar of Companies Andhra Pradesh. Subsequently the Company name was changed from Sai Advantium Pharma Limited to Sai Life Sciences Limited and a fresh Certificate of Incorporation dated May 28 2012 was issued by the Registrar of Companies Andhra Pradesh at Hyderabad.The Company is an innovatorfocused contract research development and manufacturing organization CRDMO. The Company provide endtoend services across the drug discovery development and manufacturing value chain for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both a discovery / contract research and b CMC / CDMO capabilities.Through the Scheme of Amalgamation Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later the Company opened new areas of biology facility in Watertown Greater Boston MA U.S.A. for innovative and creative smallmolecule drugs in 2019. It launched Sai Nxt an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge Massachusetts USA.In 2021 the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022 it opened the first set of new disconvery chemistry labs at Unit III Plant Hyderabad. In 2023 the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability formulations DF capabilities at Unit II Hyderabad in 2024.The Company is proposing to raise money from public through IPO by issue and allotment of 61573120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares..

Revenue: ₹556.46Cr as on December 2025 (Q3 FY26)
Net Profit: ₹100.38Cr as on December 2025 (Q3 FY26)
Listing date: 18 Dec, 2024
Chairperson Name: Ranga Raju Kanumuri
OrganisationSai Life Sciences Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORanga Raju Kanumuri
E-voting on sharesClick here to vote

FAQs

What is Sai Life Sciences share price today?

Sai Life Sciences share price today stands at ₹953.05 as on at the close of the market. Sai Life Sciences share today touched a day high of ₹1005.4 and a low of ₹938.

What is the 52 week high and 52 week low range for Sai Life Sciences share?

Sai Life Sciences touched a 52 week high of ₹1084 and a 52 week low of ₹636.1. Sai Life Sciences share price today i.e. is closed at ₹953.05, which is -12.08% down from its 52 week high and 49.83% up from its 52 week low.

What is Sai Life Sciences's market capitalisation today?

Sai Life Sciences market capitalisation is ₹20,182.56 Cr as on .

How to buy Sai Life Sciences shares?

To buy Sai Life Sciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SAILIFE or Sai Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sai Life Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sai Life Sciences trading volume today?

Sai Life Sciences trading volume is 6.47L as on . This means that 6.47L shares of Sai Life Sciences were bought and sold on the stock market during today's trading session.